Mural Oncology (MURA) Earnings Date, Estimates & Call Transcripts → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free MURA Stock Alerts $3.36 +0.01 (+0.30%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 14) -$1.84 Beat By $0.82 Consensus EPS (May. 14) -$2.66 Get Mural Oncology Earnings AlertsEnter your email address below to receive the latest news and earnings results for MURA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMURA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MURA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Mural Oncology Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($7.54) EPSNext Year EPS Consensus Estimate: ($3.94) EPSMURA Earnings Date and InformationMural Oncology last released its earnings results on May 14th, 2024. The reported ($1.84) earnings per share for the quarter, beating the consensus estimate of ($2.66) by $0.82. Mural Oncology has generated $0.00 earnings per share over the last year. Earnings for Mural Oncology are expected to grow in the coming year, from ($7.54) to ($3.94) per share. Mural Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Mural Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/14/2024Q1 2024($2.66)($1.84)+$0.82($1.84)--3/26/2024Q4 2023-($3.57)($3.57)($3.57)--12/14/2023Q3 2023-($3.07)($3.07)($3.07)-- Mural Oncology Earnings - Frequently Asked Questions When is Mural Oncology's earnings date? Mural Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on MURA's earnings history. Did Mural Oncology beat their earnings estimates last quarter? In the previous quarter, Mural Oncology (NASDAQ:MURA) reported ($1.84) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.66) by $0.82. Learn more on analysts' earnings estimate vs. MURA's actual earnings. How much profit does Mural Oncology generate each year? Mural Oncology (NASDAQ:MURA) has a recorded net income of -$207.45 million. MURA has generated $0.00 earnings per share over the last four quarters. What is Mural Oncology's EPS forecast for next year? Mural Oncology's earnings are expected to grow from ($7.54) per share to ($3.94) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Akebia Therapeutics Earnings Results 2seventy bio Earnings Results Eliem Therapeutics Earnings Results Design Therapeutics Earnings Results Aldeyra Therapeutics Earnings Results Conduit Pharmaceuticals Earnings Results Pyxis Oncology Earnings Results Ovid Therapeutics Earnings Results Renovaro Earnings Results Generation Bio Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:MURA) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
